Urokinase - Effect on Efficacy of Bcg Therapy

Hudson, M'Liss Ann

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29CA054277-02
• Application #: 3460190
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Project Start: 1991-04-01
• Project End: 1992-05-15
• Budget Start: 1992-04-01
• Budget End: 1992-05-15
• Support Year: 2
• Fiscal Year: 1992

Institution

• Name: Baylor College of Medicine
• Type: Schools of Medicine
• DUNS #: 074615394
• City: Houston
• State: TX
• Country: United States
• Zip Code: 77030

Publications

Hudson, M A; McReynold, L M (1999) Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines. Adv Exp Med Biol 462:399-412

Hudson, M A; McReynolds, L M (1997) Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines. J Natl Cancer Inst 89:709-17